REFERENCES
- Bretelle F, Courbiere B, Mazouni C, . Management of placenta accreta: Morbidity and outcome. Eur J Obstet Gynecol Reprod Biol 2007;133:34–9.
- Takeda A, Koyama K, Imoto S, . Conservative management of placenta increta after first trimester abortion by transcatheter arterial chemoembolization: A case report and review of the literature. Arch Gynecol Obstet 2010;281:381–6.
- Yang JI, Kim HY, Kim HS, Ryu HS. Diagnosis in the first trimester of placenta accreta with previous Cesarean section. Ultrasound Obstet Gynecol 2009;34: 116–8.
- Kayem G, Grange G, Schmitz T. Clinical aspects and management of morbidly adherent placenta. Eur Clinics Obstet Gynaecol 2006;2:139–45.
- Mussali GM, Shah J, Berck DJ, . Placenta accreta and methotrexate therapy: Three case reports. J Perinatol 2000;20:331–4.
- Morgan M, Atalla R. Mifepristone and misoprostol for the management of placenta accreta – A new alternative approach. BJOG 2009;116:1002–3.
- Dilauro MD, Dason S, Athreya S. Prophylactic balloon occlusion of internal iliac arteries in women with placenta accreta: Literature review and analysis. Clin Radiol 2012; doi:10.1016:j.crad.2011.10.031 (in press)
- Alanis M, Hurst BS, Marshburn PB, Matthews ML. Conservative management of placenta increta with selective embolization preserves future fertility and results in a favorable outcome in subsequent pregnancies. Fertil Steril 2006;86:1514.